Sign Up to like & get
recommendations!
0
Published in 2019 at "Tumor Biology"
DOI: 10.1158/1538-7445.am2019-2875
Abstract: Most anticancer therapies are unspecific and therefore inevitably lead to off-target toxicity. To overcome these shortcomings, targetable hybrid polymerization liposomal nanoparticles (HPLNs) have been invented. Multiple innovative and proprietary technologies have been developed to enable…
read more here.
Keywords:
liposomal nanoparticles;
hplns encapsulating;
tumor;
cd99 ... See more keywords